News

Filter

Current filters:

None

8137 to 8146 of 97252 results

European approval for Mundipharma/SkyePharma's asthma drug Flutiform

04-07-2012

After some delays, the European Commission has now adopted a legally binding decision in favor of granting…

EuropeFlutiformMundipharmaPharmaceuticalRegulationRespiratory and PulmonarySkyepharma

AnGes deal with Mitsubishi Tanabe Pharma for Collategene in USA

04-07-2012

AnGes MG (TYO: 4563) has concluded a basic agreement with fellow Japanese drugmaker Mitsubishi Tanabe…

AnGes MDCardio-vascularCollategeneLicensingMitsubishi TanabePharmaceutical

Sinclair IS returns Episil rights to Camurus, retaining some distribution

04-07-2012

UK-based specialty drugmaker Sinclair IS Pharma (AIM: SPH.L) has returned the commercial rights for Episil(…

CamurusEpisilLicensingNeurologicalPharmaceuticalSinclair IS Pharma

GSK settlement still not enough to deter Pharma, says Public Citizen

03-07-2012

This week's announcement of the largest health fraud settlement ever reached between a pharmaceutical…

FinancialGlaxoSmithKlineLegalMarkets & MarketingPharmaceutical

News briefs: Priority review for ocriplasmin; Zonegran monotherapy in EU

03-07-2012

Belgium-based biopharma firm ThromboGenics (Euronext Brussels: THR) says that the US Food and Drug Administration…

EisaiEuropeNeurologicalNorth AmericaocriplasminOphthalmicsPharmaceuticalRegulationThromboGenicsZonegran

Antivirals market facing generics threat, especially for HIV drugs

03-07-2012

Generic copies of branded drugs are predicted to take over the antiviral drugs market, especially in…

Anti-viralsGenericsMarkets & MarketingPatentsPharmaceutical

Botulinum toxin a shot in the arm for preventing MS tremor

03-07-2012

Botulinum toxin may help prevent shaking or tremor in the arms and hands of people with multiple sclerosis…

Botulinum toxinNeurologicalPharmaceuticalResearch

Blackmores acquires FIT-BioCeuticals for A$40 million

03-07-2012

Australia's Blackmores (ASX:BKL) says that it has agreed to acquire 100% of the issued share capital…

Asia-PacificBlackmoresFIT-BioCeuticalsMergers & AcquisitionsPharmaceutical

GlaxoSmithKline to plead guilty and pay record $3 billion to resolve US fraud allegations

03-07-2012

UK pharma giant GlaxoSmithKline (LSE: GSK) has agreed to plead guilty and to pay $3 billion - the largest…

FinancialGlaxoSmithKlineLegalMarkets & MarketingNorth AmericaPharmaceutical

8137 to 8146 of 97252 results

Back to top